USE OF A BEARABLE CONTINUOUS INTERSTITIAL GLUCOSE MONITORING DEVICE (GUARDIANR) DURING TEACHING SESSIONS TO FUNCTIONAL INSULIN THERAPY CONCEPT IN PATIENTS SUFFERING FROM TYPE 1 DIABETES: EVALUATION AT 6 AND 12 MONTHS: